Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Neurooncol. 2019 Feb 22;142(3):479–487. doi: 10.1007/s11060-019-03119-w

Figure 2: Boxplots for genotypically-estimated leukocyte telomere length and meningioma case-control status by sequencing panel.

Figure 2:

The boxplots depicting the distribution of genotypically-estimated leukocyte telomere length (LTL) in meningioma patients and controls. Separate boxplots are depicted for the who different sample sources and overall. The p-values were 0.0009, 0.003, 2.13×10−5 for the telomere SNP panel, the meningioma consortium, and overall in a logistic regression model with gender and the first two ancestral principal components as covariates. The model for the overall analysis was also corrected for sequencing panel used.